Our findings showed that the obesity group showed significantly higher fasting glucose, HOMA-IR, TC, LDL, ALT, and AST levels than did the control group, and these levels significantly improved after weight loss with the life intervention. The gene discussed is GPT; the disease is obesity disorder.